The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, X. M.
Right arrow Articles by Tite, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, X. M.
Right arrow Articles by Tite, J.

The Journal of Immunology, Vol 147, Issue 10 3268-3273, Copyright © 1991 by American Association of Immunologists


ARTICLES

Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides

XM Gao, B Zheng, FY Liew, S Brett and J Tite
Department of Cell Biology, Wellcome Research Labs, Beckenham, Kent, U.K.

Influenza virus-specific CTL were primed in vivo by immunization with short synthetic peptides representing major CTL epitopes from the nucleoprotein of type A influenza virus. The resultant CTL after in vitro boosting of primed spleen cells recognized both virus-infected and peptide-pulsed target cells. The requirement of CD4+ T cell activation was investigated in several ways. First the addition of helper epitopes to the CTL epitope did not enhance CTL generation, suggesting that helper activity was either not limiting or not required. However, in vivo depletion of CD4+ T cells completely inhibited the generation of CTL by peptide immunization. The inclusion of anti-CD4 in the in vitro restimulation with peptide also prevented the generation of CTL, whereas in vitro reactivation of virus immune spleen cells with peptide was not inhibited by anti-CD4. Thus there appears to be heterogeneity in the requirement of CD4+ T cell proliferation in CTL generation. One possibility is that virus infected cells can stimulate higher affinity T cells that are less helper T cell dependent.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. S. Bijker, S. J. F. van den Eeden, K. L. Franken, C. J. M. Melief, R. Offringa, and S. H. van der Burg
CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund's Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity
J. Immunol., October 15, 2007; 179(8): 5033 - 5040.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Deliyannis, D. C. Jackson, N. J. Ede, W. Zeng, I. Hourdakis, E. Sakabetis, and L. E. Brown
Induction of Long-Term Memory CD8+ T Cells for Recall of Viral Clearing Responses against Influenza Virus
J. Virol., March 27, 2002; 76(9): 4212 - 4221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Wallin, L. Liang, A. Bakardjiev, and W. C. Sha
Enhancement of CD8+ T Cell Responses by ICOS/B7h Costimulation
J. Immunol., July 1, 2001; 167(1): 132 - 139.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Muderspach, S. Wilczynski, L. Roman, L. Bade, J. Felix, L. A. Small, W. M. Kast, G. Fascio, V. Marty, and J. Weber
A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive
Clin. Cancer Res., September 1, 2000; 6(9): 3406 - 3416.
[Abstract] [Full Text]


Home page
J. Virol.Home page
C. Sedlik, G. Dadaglio, M. F. Saron, E. Deriaud, M. Rojas, S. I. Casal, and C. Leclerc
In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity
J. Virol., July 1, 2000; 74(13): 5769 - 5775.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
A. L.-D. de Cerio, N. Casares, J. J. Lasarte, P. Sarobe, L. A. Perez-Mediavilla, M. Ruiz, J. Prieto, and F. Borras-Cuesta
Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides
Int. Immunol., December 1, 1999; 11(12): 2025 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. Harling-McNabb, G. Deliyannis, D. C. Jackson, S. Gerondakis, G. Grigoriadis, and L. E. Brown
Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response
Int. Immunol., September 1, 1999; 11(9): 1431 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Moskophidis and D. Kioussis
Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model
J. Exp. Med., July 20, 1998; 188(2): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B Zheng, S. Brett, J. Tite, M. Lifely, T. Brodie, and J Rhodes
Galactose oxidation in the design of immunogenic vaccines
Science, June 12, 1992; 256(5063): 1560 - 1563.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.